17 November 2017
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics investigates the safety and efficacy of vaptans in cirrhosis with ascites or hyponatremia.
Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. <
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors